Josep Maria Domingo-domenech

Mayo Clinic

NIH Rank #5722
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#5,722
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.9M across 4 grants · National rank #5722.

Top grants by award amount

Josep Maria Domingo-domenech's NIH grant portfolio, ranked by award amount.

  • 1R01CA280999-01A1R01
    Mechanisms and therapeutic targeting of lethal prostate cancer master regulator transcription factors
    $532.6K
    award amount
  • 1R01CA285345-01R01
    Mechanism and therapeutic targeting of castration resistance in SPOP-mutated prostate cancer
    $507.4K
    award amount
  • 1R01CA286864-01R01
    Mechanism and therapeutic targeting of abnormal androgenesis in CHD1-deficient prostate cancer
    $452.2K
    award amount
  • 5R01CA261925-04R01
    Determine the Microphthalmia Transcription Factor (MITF)-regulated cell rewiring mechanisms in lethal prostate cancer
    $434.9K
    award amount

Affiliation

Institutions that have administered grants for Josep Maria Domingo-domenech.

Affiliated with Mayo Clinic (AZ).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Mayo Clinic
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5722